1. Home
  2. PVLA vs AREN Comparison

PVLA vs AREN Comparison

Compare PVLA & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • AREN
  • Stock Information
  • Founded
  • PVLA 2015
  • AREN 2016
  • Country
  • PVLA United States
  • AREN United States
  • Employees
  • PVLA N/A
  • AREN N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • AREN Medical/Dental Instruments
  • Sector
  • PVLA Health Care
  • AREN Health Care
  • Exchange
  • PVLA Nasdaq
  • AREN Nasdaq
  • Market Cap
  • PVLA 285.2M
  • AREN 305.8M
  • IPO Year
  • PVLA N/A
  • AREN N/A
  • Fundamental
  • Price
  • PVLA $53.42
  • AREN $6.56
  • Analyst Decision
  • PVLA Strong Buy
  • AREN Strong Buy
  • Analyst Count
  • PVLA 11
  • AREN 1
  • Target Price
  • PVLA $56.64
  • AREN $12.00
  • AVG Volume (30 Days)
  • PVLA 153.4K
  • AREN 233.4K
  • Earning Date
  • PVLA 08-14-2025
  • AREN 08-14-2025
  • Dividend Yield
  • PVLA N/A
  • AREN N/A
  • EPS Growth
  • PVLA N/A
  • AREN N/A
  • EPS
  • PVLA N/A
  • AREN 2.74
  • Revenue
  • PVLA N/A
  • AREN $146,610,000.00
  • Revenue This Year
  • PVLA N/A
  • AREN $31.49
  • Revenue Next Year
  • PVLA N/A
  • AREN $10.00
  • P/E Ratio
  • PVLA N/A
  • AREN $2.41
  • Revenue Growth
  • PVLA N/A
  • AREN 6.81
  • 52 Week Low
  • PVLA $11.17
  • AREN $0.56
  • 52 Week High
  • PVLA $53.93
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 85.86
  • AREN 51.00
  • Support Level
  • PVLA $46.08
  • AREN $6.25
  • Resistance Level
  • PVLA $50.22
  • AREN $7.61
  • Average True Range (ATR)
  • PVLA 3.11
  • AREN 0.66
  • MACD
  • PVLA 0.70
  • AREN -0.06
  • Stochastic Oscillator
  • PVLA 97.00
  • AREN 30.27

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: